Copyright
©The Author(s) 2022.
World J Gastroenterol. May 14, 2022; 28(18): 2008-2020
Published online May 14, 2022. doi: 10.3748/wjg.v28.i18.2008
Published online May 14, 2022. doi: 10.3748/wjg.v28.i18.2008
Table 1 Baseline characteristics for participants with and without major gastrointestinal bleedings during follow-up
Baseline characteristics | GIB, n = 403 | No GIB, n = 33105 | Overall, n = 33508 |
Age at baseline, mean (SD) | 56.0 (12.1) | 46.8 (13.0) | 46.9 (13.0) |
Sex | |||
Male | 256 (63.5) | 15768 (47.6) | 16024 (47.8) |
Female | 147 (36.5) | 17337 (52.4) | 17484 (52.2) |
Yr of enrollment, Q1 | |||
1987 | 45 (11.2) | 5872 (17.7) | 5917 (17.7) |
1992 | 51 (12.7) | 5371 (16.2) | 5422 (16.2) |
1997 | 126 (31.3) | 7857 (23.7) | 7983 (23.8) |
2002 | 108 (26.8) | 8155 (24.6) | 8263 (24.7) |
2007 | 73 (18.1) | 5850 (17.7) | 5923 (17.7) |
Region1 | |||
West | 163 (40.4) | 12570 (38.0) | 12733 (38.0) |
East | 240 (59.6) | 20535 (62.0) | 20775 (62.0) |
Marital status | |||
Married, cohabiting, or registered partnership | 278 (69.0) | 24391 (73.7) | 24669 (73.6) |
Single, separated, divorced, or widow | 125 (31.0) | 8623 (26.0) | 8748 (26.1) |
Missing | 0 (0.0) | 91 (0.3) | 91 (0.3) |
Occupation | |||
Non-manual (office/studying) | 102 (25.3) | 15889 (48.0) | 15991 (47.7) |
Manual (factory/construction/farming/forestry) | 62 (15.4) | 6692 (20.2) | 6754 (20.2) |
Family/housewife/pensioner | 191 (47.4) | 8033 (24.3) | 8224 (24.5) |
Unemployed | 37 (9.2) | 2006 (6.1) | 2043 (6.1) |
Missing | 11 (2.7) | 485 (1.5) | 496 (1.5) |
Education in tertiles2 | |||
Low | 128 (31.8) | 10029 (30.3) | 10157 (30.3) |
Moderate | 113 (28.0) | 10735 (32.4) | 10848 (32.4) |
High | 144 (35.7) | 11619 (35.1) | 11763 (35.1) |
Missing | 18 (4.5) | 722 (2.2) | 740 (2.2) |
Smoking | |||
Never | 168 (41.7) | 17381 (52.5) | 17549 (52.4) |
Ex-smoker | 121 (30.0) | 7028 (21.2) | 7149 (21.3) |
Smoker | 105 (26.1) | 8273 (25.0) | 8378 (25.0) |
Missing | 9 (2.2) | 423 (1.3) | 432 (1.3) |
Alcohol consumption in grams per week | |||
Non-drinker | 164 (40.7) | 12548 (37.9) | 12712 (37.9) |
Mild (0.1 g to 36.9 g) | 65 (16.1) | 6835 (20.6) | 6900 (20.6) |
Moderate (37 g to 86.9 g) | 54 (13.4) | 5914 (17.9) | 5968 (17.8) |
Heavy (≥ 87g) | 101 (25.1) | 6879 (20.8) | 6980 (20.8) |
Missing | 19 (4.7) | 929 (2.8) | 948 (2.8) |
Coffee consumption per day, cups | |||
0 | 38 (9.4) | 2858 (8.6) | 2896 (8.6) |
1–5 | 267 (66.3) | 20294 (61.3) | 20561 (61.4) |
6–10 | 86 (21.3) | 9008 (27.2) | 9094 (27.1) |
> 10 | 4 (1.0) | 637 (1.9) | 641 (1.9) |
Missing | 8 (2.0) | 308 (0.9) | 316 (0.9) |
Physical activity | |||
Minimal to mild | 335 (83.1) | 25306 (76.4) | 25641 (76.5) |
Moderate to heavy | 52 (12.9) | 7095 (21.4) | 7147 (21.3) |
Missing | 16 (4.0) | 704 (2.1) | 720 (2.1) |
Body mass index in kg/m2, mean (SD) | 28.3 (5.2) | 26.6 (4.6) | 26.6 (4.6) |
Missing | 10 (2.5) | 389 (1.2) | 399 (1.2) |
Waist-hip ratio, mean (SD) | 0.93 (0.1) | 0.88 (0.1) | 0.88 (0.1) |
Missing | 5 (1.2) | 404 (1.2) | 409 (1.2) |
Systolic blood pressure in mm Hg, mean (SD) | 141.0 (22) | 136.0 (20) | 136.0 (20) |
Missing | 2 (0.5) | 268 (0.8) | 270 (0.8) |
Diastolic blood pressure in mm Hg, mean (SD) | 83.5 (12.7) | 81.0 (11.7) | 81.0 (11.7) |
Missing | 2 (0.5) | 271 (0.8) | 273 (0.8) |
Total cholesterol in mmol/L, mean (SD) | 5.69 (1.09) | 5.58 (1.12) | 5.58 (1.12) |
Missing | 5 (1.2) | 347 (1.0) | 352 (1.1) |
High density lipoprotein in mmol/L, mean (SD) | 1.39 (0.44) | 1.44 (0.38) | 1.44 (0.38) |
Missing | 5 (1.2) | 347 (1.0) | 352 (1.1) |
Gamma-glutamyl transferase in U/L, mean (SD) | 59.5 (141) | 31.2 (45.0) | 31.5 (47.4) |
Missing | 5 (1.2) | 356 (1.1) | 361 (1.1) |
Table 2 Medical history in participants with and without gastrointestinal bleeding
Comorbidities | GIB, n = 403 | No GIB, n = 33105 | Overall, n = 33508 |
Precursors of GIBs1 | |||
0 | 355 (88.1) | 31621 (95.5) | 31976 (95.4) |
1 | 45 (11.2) | 1399 (4.2) | 1444 (4.3) |
2 | 3 (0.7) | 78.0 (0.2) | 81.0 (0.2) |
3 | 0 (0) | 7.00 (0.0) | 7.00 (0.0) |
Any cancer | 63 (15.6) | 2421 (7.3) | 2484 (7.4) |
Any psychiatric disorders | 104 (25.8) | 4653 (14.1) | 4757 (14.2) |
Stroke including SAH | 39 (9.7) | 1239 (3.7) | 1278 (3.8) |
Venous thromboembolism | 17 (4.2) | 728 (2.2) | 745 (2.2) |
Ischemic heart disease | 101 (25.1) | 3433 (10.4) | 3534 (10.5) |
Valvular heart disease | 23 (5.7) | 689 (2.1) | 712 (2.1) |
Atrial fibrillation | 55 (13.6) | 1512 (4.6) | 1567 (4.7) |
Peripheral artery disease | 23 (5.7) | 553 (1.7) | 576 (1.7) |
Heart failure | 76 (18.9) | 1810 (5.5) | 1886 (5.6) |
High blood pressure | 128 (31.8) | 6572 (19.9) | 6700 (20.0) |
Osteoarthritis | 20 (5.0) | 2062 (6.2) | 2082 (6.2) |
Inflammatory connective tissue diseases | 29 (7.2) | 1458 (4.4) | 1487 (4.4) |
Diabetes2 | 52 (12.9) | 2390 (7.2) | 2442 (7.3) |
COPD | 24 (6.0) | 638 (1.9) | 662 (2.0) |
Asthma | 54 (13.4) | 3828 (11.6) | 3882 (11.6) |
Liver disorder | 29 (7.2) | 389 (1.2) | 418 (1.2) |
Anemia | 6 (1.5) | 70 (0.2) | 76 (0.2) |
Table 3 Multivariate analysis for the risk factors for major gastrointestinal bleeding
Variables | Univariate model, HR (95%CI) | Multivariate model, HR (95%CI) |
Baseline age (10-yr increase) | 1.83 (1.69–1.99) | 1.62 (1.42–1.86) |
Sex | ||
Male | 1 | 1 |
Female | 0.51 (0.42–0.63) | 0.83 (0.59–1.17) |
Yr of enrollment | ||
1987 | 1 | 1 |
1992 | 1.23 (0.83-1.84) | 1.15 (0.74–1.79) |
1997 | 2.10 (1.50–2.96) | 1.36 (0.91–2.04) |
2002 | 1.72 (1.21–2.43) | 1.10 (0.72–1.68) |
2007 | 1.66 (1.15–2.41) | 0.90 (0.57–1.43) |
Region1 | ||
West Finland | 1 | 1 |
East Finland | 0.90 (0.74–1.10) | 0.96 (0.77–1.20) |
Marital status | ||
Married, cohabiting, or registered partnership | 1 | 1 |
Single, separated, divorced, or widow | 1.29 (1.04–1.59) | 1.09 (0.86–1.38) |
Occupation | ||
Non-manual (office/studying) | 1 | 1 |
Manual (factory/ construction/ farming/ forestry) | 1.45 (1.06–1.98) | 1.25 (0.88–1.78) |
Family/ housewife/ pensioner | 3.90 (3.06–4.95) | 1.26 (0.90–1.75) |
Unemployed | 2.92 (2.00–4.25) | 1.70 (1.11–2.59) |
Education2 | ||
Low | 1 | 1 |
Moderate | 0.82 (0.64–1.06) | 0.81 (0.62–1.06) |
High | 0.96 (0.76–1.22) | 1.05 (0.80–1.38) |
Smoking | ||
Never | 1 | 1 |
Ex-smoker | 1.80 (1.43–2.28) | 1.18 (0.90–1.53) |
Smoker | 1.34 (1.05–1.71) | 1.30 (0.97–1.74) |
Alcohol consumption in grams per week | ||
Non-User | 1 | 1 |
Mild (0.1 g to 36.9 g) | 0.72 (0.54–0.96) | 0.88 (0.66–1.19) |
Moderate (37 g to 86.9 g) | 0.69 (0.51–0.94) | 0.76 (0.54–1.06) |
Heavy (≥ 87 g) | 1.13 (0.88–1.44) | 1.02 (0.76–1.37) |
Coffee consumption per day, cups | ||
0 | 1 | 1 |
1–5 | 1.00 (0.71–1.40) | 0.72 (0.50–1.02) |
6–10 | 0.72 (0.49–1.06) | 0.67 (0.46–0.99) |
> 10 | 0.48 (0.17–1.33) | 0.43 (0.23–0.81) |
Physical activity | ||
None to Mild | 1 | 1 |
Moderate to Heavy | 0.55 (0.41–0.73) | 0.85 (0.62–1.16) |
Body mass index standardized | 1.38 (1.27–1.50) | 1.15 (1.01–1.32) |
Waist hip ratio standardized | 1.70 (1.55–1.86) | 1.18 (0.98–1.43) |
Systolic blood pressure standardized | 1.30 (1.19–1.42) | 0.85 (0.76-0.96) |
Diastolic blood pressure standardized | 1.24 (1.13–1.37) | - |
Total cholesterol standardized | 1.10 (1.00–1.21) | 0.94 (0.84–1.05) |
High density lipoprotein standardized | 0.86 (0.77–0.95) | - |
Gamma-glutamyl transferase standardized | 1.10 (1.08–1.12) | 1.05 (1.02-1.09) |
Precursors of GIB3 | ||
0 | 1 | 1 |
≥ 1 | 9.44 (7.65–11.65) | 1.90 (1.37–2.63) |
Any cancer | 2.66 (2.03–3.48) | 1.47 (1.10–1.97) |
Any psychiatric disorders | 2.21 (1.77–2.77) | 1.32 (1.01–1.71) |
Stroke including SAH | 2.98 (2.14–4.15) | 1.31 (0.90–1.90) |
Venous thromboembolism | 2.04 (1.26–3.32) | - |
Ischemic heart disease | 3.14 (2.51–3.94) | 1.16 (0.87-1.55) |
Valvular heart disease | 2.91 (1.91–4.44) | 1.40 (0.88-2.25) |
Atrial fibrillation | 3.46 (2.60–4.60) | 1.05 (0.73–1.51) |
Peripheral artery disease | 3.94 (2.59–6.00) | 1.39 (0.87–2.23) |
Heart failure | 4.35 (3.39–5.58) | 1.46 (1.04–2.05) |
High blood pressure | 1.92 (1.55–2.36) | 0.90 (0.69–1.17) |
Osteoarthritis | 0.78 (0.50–1.23) | 0.39 (0.24–0.65) |
Connective tissue diseases | 1.72 (1.18–2.51) | - |
Diabetes4 | 1.97 (1.47–2.64) | 0.76 (0.54–1.08) |
Chronic obstructive pulmonary disease | 3.57 (2.36–5.39) | 1.26 (0.77–2.06) |
Asthma | 1.19 (0.89–1.58) | 0.80 (0.58–1.11) |
Liver disorder | 6.95 (4.76–10.15) | 3.20 (2.06–4.97) |
Anemia | 7.16 (3.20–16.04) | 1.52 (0.48–4.83) |
- Citation: Vora P, Herrera R, Pietila A, Mansmann U, Brobert G, Peltonen M, Salomaa V. Risk factors for major gastrointestinal bleeding in the general population in Finland. World J Gastroenterol 2022; 28(18): 2008-2020
- URL: https://www.wjgnet.com/1007-9327/full/v28/i18/2008.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i18.2008